Found 55 results in Expert Content

Abstract: Spray drying has evolved beyond amorphous solid dispersions to become a scalable, versatile manufacturing platform for small molecules, peptides, biologics, and emerging modalities.

Abstract: Pulmonary drug delivery is no longer limited to asthma and COPD. The field now spans hundreds of active programs, many led by emerging biotechs that must make early, high-impact decisions with limited data.

Abstract: Selling CDMO services is a complex task that calls for broad skill and technical depth.

Summary:​ Drug development today is shaped by 2 forces: the technical challenge of formulating complex molecules and the external challenge of navigating unstable global supply chains.

Summary: Late-stage scaling of spray drying for inhaled formulations can result in avoidable delays, post-approval issues, and cost overruns.

Summary: Inhalation powders have been used for decades to treat lung diseases and conditions requiring rapid systemic therapy.

Developers of innovative drug products dealing with protein formulations, nucleotide-based drugs, peptides, and poorly soluble molecules, face significant challenges in achieving efficient and scalable manufacturing solutions.

Developers of innovative drug products dealing with protein formulations, nucleotide-based drugs, peptides, and poorly soluble molecules, face significant challenges in achieving efficient and scalable manufacturing solutions.

Summary: This article provides an in-depth review of milling equipment, including jet, pin, hammer, conical, and cryogenic mills.

Nasal development is an attractive option but can be difficult, requiring expertise to overcome formulation challenges, and to navigate the complexities of drug/device combination products to optimize drug delivery.